SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-006319
Filing Date
2024-05-01
Accepted
2024-05-01 06:30:13
Documents
15
Period of Report
2024-05-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20240501x8k.htm   iXBRL 8-K 36018
2 EX-99.1 tmb-20240501xex99d1.htm EX-99.1 596984
3 EX-99.2 tmb-20240501xex99d2.htm EX-99.2 21226
  Complete submission text file 0001558370-24-006319.txt   812534

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20240501.xsd EX-101.SCH 3108
5 EX-101.LAB tmb-20240501_lab.xml EX-101.LAB 15267
6 EX-101.PRE tmb-20240501_pre.xml EX-101.PRE 10905
18 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240501x8k_htm.xml XML 4602
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

IRS No.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17272 | Film No.: 24899953
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)